Elite in Myocarditis

Carsten Skurk

Potsdamer Str. 58, 
Berlin, BE, DE 
Elite in Myocarditis
Potsdamer Str. 58, 
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Carsten Skurk practices in Berlin, Germany. Mr. Skurk is rated as an Elite expert by MediFind in the treatment of Myocarditis. His top areas of expertise are Cardiogenic Shock, Myocarditis, Heart Attack, Percutaneous Coronary Intervention (PCI), and Lithotripsy.

His clinical research consists of co-authoring 170 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of Myocarditis.

Gender
Male

Locations

Potsdamer Str. 58, Berlin, BE 10785, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Enrollment Status: Completed
Publish Date: September 18, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2025
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

170 Total Publications

Extracorporeal Membrane Oxygenation Complications Are Not Causal for Mortality in Patients With Infarct-Related Cardiogenic Shock: A Mediation Analysis of the Extracorporeal Life Support in Infarct-Related Cardiogenic Shock (ECLS-SHOCK) Trial.
Extracorporeal Membrane Oxygenation Complications Are Not Causal for Mortality in Patients With Infarct-Related Cardiogenic Shock: A Mediation Analysis of the Extracorporeal Life Support in Infarct-Related Cardiogenic Shock (ECLS-SHOCK) Trial.
Journal: Critical care medicine
Published: October 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Skurk's expertise for a condition
ConditionClose
View All 29 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile